Jaka jest cena za LumiraDx Limited (LMDX)

Cena za LumiraDx Limited (LMDX) wynosi $0.016

Jaka jest kapitalizacja rynkowa dla LumiraDx Limited (LMDX)

Kapitalizacja rynkowa dla LumiraDx Limited (LMDX) wynosi $5.10M

LumiraDx Limited (LMDX) Podziały Akcji

LumiraDx Limited is a prominent provider of point-of-care diagnostic solutions. Its core mission is to revolutionize community healthcare by equipping medical professionals with crucial diagnostic insights directly at the patient's side. The company develops and commercializes a sophisticated diagnostic platform, offering a diverse array of tests that deliver laboratory-grade performance directly at the point of care. With approximately 30 tests either commercially available or under development, their comprehensive portfolio addresses critical conditions such as infectious diseases, cardiovascular disorders, diabetes, and coagulation issues. Furthermore, they offer a full suite of COVID-19 testing solutions, adaptable for both laboratory environments and immediate point-of-need applications. These diagnostic tools are widely adopted by governments and healthcare institutions, deployed in diverse settings including traditional laboratories, urgent care clinics, physician's offices, pharmacies, schools, and workplaces. Their applications span screening, diagnosis, and monitoring for both general wellness and specific diseases. Established in 2014, the company's headquarters are located in London, United Kingdom.

Rok	Podział	Mnożnik	Skumulowany mnożnik
Za mało danych dla podanych dat.

Rok

Podział

Mnożnik

Skumulowany mnożnik

Za mało danych dla podanych dat.

Firma	Liczba podziałów akcji	Skumulowany mnożnik	Kraj
Thermo Fisher Scientific Inc. TMO.US	8	x34	US
Danaher Corporation DHR.US	7	x47	US
WuXi AppTec Co., Ltd. 603259.SS	0	-	CN
Natera, Inc. NTRA.US	0	-	US
IDEXX Laboratories, Inc. IDXX.US	4	x15	US

Firma

Liczba podziałów akcji

Skumulowany mnożnik

Kraj